TRAPPC5

gene
On this page

Also known as MGC52424TRS31

Summary

TRAPPC5 (trafficking protein particle complex subunit 5, HGNC:23067) is a protein-coding gene on chromosome 19p13.2, encoding Trafficking protein particle complex subunit 5 (Q8IUR0). May play a role in vesicular transport from endoplasmic reticulum to Golgi. It is a common-essential gene (DepMap: required in 94.5% of cancer cell lines).

Predicted to be involved in endoplasmic reticulum to Golgi vesicle-mediated transport. Part of TRAPP complex.

Source: NCBI Gene 126003 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 23 total
  • Druggable target: yes
  • Cancer dependency (DepMap): dependent in 94.5% of screened cell lines (common-essential)
  • MANE Select transcript: NM_001042462

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:23067
Approved symbolTRAPPC5
Nametrafficking protein particle complex subunit 5
Location19p13.2
Locus typegene with protein product
StatusApproved
AliasesMGC52424, TRS31
Ensembl geneENSG00000181029
Ensembl biotypeprotein_coding
Entrez126003

Gene structure

Transcript identifiers

Ensembl transcripts: 5 — 5 protein_coding

ENST00000317378, ENST00000426877, ENST00000595985, ENST00000596148, ENST00000944764

RefSeq mRNA: 3 — MANE Select: NM_001042462 NM_001042461, NM_001042462, NM_174894

CCDS: CCDS42490

Canonical transcript exons

ENST00000596148 — 2 exons

ExonStartEnd
ENSE0000302716576808337680878
ENSE0000349359076822427687703

Expression profiles

Bgee: expression breadth ubiquitous, 133 present calls, max score 98.20.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 91.2116 / max 521.7233, expressed in 1828 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
17359690.32631828
2086770.8853588

Top tissues by expression

133 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left testisUBERON:000453398.20gold quality
right testisUBERON:000453498.04gold quality
stromal cell of endometriumCL:000225597.70gold quality
superior frontal gyrusUBERON:000266197.61gold quality
prefrontal cortexUBERON:000045197.48gold quality
primary visual cortexUBERON:000243697.45gold quality
hindlimb stylopod muscleUBERON:000425297.43gold quality
olfactory segment of nasal mucosaUBERON:000538697.01gold quality
lower esophagus mucosaUBERON:003583496.85gold quality
granulocyteCL:000009496.78gold quality
Brodmann (1909) area 9UBERON:001354096.48gold quality
testisUBERON:000047396.02gold quality
frontal cortexUBERON:000187095.41gold quality
dorsolateral prefrontal cortexUBERON:000983494.72gold quality
cerebral cortexUBERON:000095694.58gold quality
bloodUBERON:000017894.48gold quality
putamenUBERON:000187494.34gold quality
bone marrow cellCL:000209294.20gold quality
apex of heartUBERON:000209894.10gold quality
leukocyteCL:000073893.87gold quality
temporal lobeUBERON:000187193.78gold quality
monocyteCL:000057693.71gold quality
amygdalaUBERON:000187693.68gold quality
Ammon’s hornUBERON:000195493.68gold quality
nucleus accumbensUBERON:000188293.67gold quality
caudate nucleusUBERON:000187393.50gold quality
anterior cingulate cortexUBERON:000983593.48gold quality
brainUBERON:000095593.29gold quality
bone marrowUBERON:000237193.24gold quality
cortex of kidneyUBERON:000122593.14gold quality

Single-cell (SCXA)

Detected in 5 experiment(s), a significant marker in 5.

ExperimentMarker?Max mean expression
E-HCAD-4yes179.42
E-MTAB-7037yes115.26
E-HCAD-6yes38.86
E-CURD-112yes20.17
E-ANND-3yes11.32

Regulation

Is transcription factor: no

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 94.5% of screened cell lines, common-essential.

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriotrappc5ENSDARG00000026068
mus_musculusTrappc5ENSMUSG00000040236
rattus_norvegicusTrappc5ENSRNOG00000001003
drosophila_melanogasterTrs31FBGN0266723
caenorhabditis_elegansWBGENE00013259

Protein

Protein identifiers

Trafficking protein particle complex subunit 5Q8IUR0 (reviewed: Q8IUR0)

All UniProt accessions (2): Q8IUR0, M0QZQ8

UniProt curated annotations — full annotation on UniProt →

Function. May play a role in vesicular transport from endoplasmic reticulum to Golgi.

Subunit / interactions. Component of the multisubunit TRAPP (transport protein particle) complex, which includes at least TRAPPC2, TRAPPC2L, TRAPPC3, TRAPPC3L, TRAPPC4, TRAPPC5, TRAPPC8, TRAPPC9, TRAPPC10, TRAPPC11 and TRAPPC12.

Subcellular location. Golgi apparatus. cis-Golgi network. Endoplasmic reticulum.

Similarity. Belongs to the TRAPP small subunits family. BET3 subfamily.

RefSeq proteins (3): NP_001035926, NP_001035927, NP_777554 (=MANE)

Domains & families (InterPro)

IDNameType
IPR007194TRAPP_componentFamily
IPR016696TRAPP-I_su5Family
IPR024096NO_sig/Golgi_transp_ligand-bdHomologous_superfamily

Pfam: PF04051

UniProt features (3 total): chain 1, modified residue 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8IUR0-F185.790.57

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 10

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-204005COPII-mediated vesicle transport
R-HSA-8876198RAB GEFs exchange GTP for GDP on RABs

MSigDB gene sets: 109 (showing top): GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP, GOBP_VESICLE_LOCALIZATION, GOBP_VESICLE_ORGANIZATION, GOBP_VESICLE_TARGETING, GOBP_VESICLE_MEDIATED_TRANSPORT, REACTOME_MEMBRANE_TRAFFICKING, GOBP_ENDOPLASMIC_RETICULUM_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT, HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP, GOBP_MEMBRANE_ORGANIZATION, BURTON_ADIPOGENESIS_PEAK_AT_24HR, GOBP_ORGANELLE_LOCALIZATION, LEE_AGING_CEREBELLUM_UP, MARSON_BOUND_BY_FOXP3_STIMULATED, GOCC_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT, chr19p13

GO Biological Process (6): endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888), vesicle coat assembly (GO:0006901), COPII vesicle coat assembly (GO:0048208), obsolete vesicle tethering (GO:0099022), vesicle-mediated transport (GO:0016192), Golgi vesicle transport (GO:0048193)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (8): cytoplasm (GO:0005737), endoplasmic reticulum (GO:0005783), cytosol (GO:0005829), TRAPP complex (GO:0030008), TRAPPI protein complex (GO:1990070), TRAPPII protein complex (GO:1990071), TRAPPIII protein complex (GO:1990072), Golgi apparatus (GO:0005794)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
ER to Golgi Anterograde Transport1
Rab regulation of trafficking1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cytoplasm4
TRAPP complex3
cellular anatomical structure2
endomembrane system2
intracellular membrane-bounded organelle2
Golgi apparatus2
intercellular transport1
intracellular transport1
Golgi vesicle transport1
vesicle budding from membrane1
vesicle organization1
vesicle coat assembly1
protein-containing complex assembly1
COPII-coated vesicle budding1
transport1
cellular process1
vesicle-mediated transport1
binding1
intracellular anatomical structure1
vesicle tethering complex1
intracellular protein-containing complex1
endoplasmic reticulum-Golgi intermediate compartment1
endosome1

Protein interactions and networks

STRING

1150 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TRAPPC5TRAPPC6AO75865998
TRAPPC5TRAPPC1Q9Y5R8998
TRAPPC5TRAPPC4Q9Y296998
TRAPPC5TRAPPC2P0DI81997
TRAPPC5TRAPPC3O43617997
TRAPPC5TRAPPC8Q9Y2L5980
TRAPPC5TRAPPC9Q96Q05938
TRAPPC5TRAPPC10P48553882
TRAPPC5TRAPPC13A5PLN9775
TRAPPC5TRAPPC12Q8WVT3766
TRAPPC5RAB1AP11476761
TRAPPC5TRAPPC11Q7Z392744
TRAPPC5TRAPPC6BQ86SZ2676
TRAPPC5TRAPPC2LQ9UL33667
TRAPPC5SETXQ7Z333505

IntAct

116 interactions, top by confidence:

ABTypeScore
MED20MED19psi-mi:“MI:0914”(association)0.840
RUFY4NDC80psi-mi:“MI:0914”(association)0.830
CCNDBP1TRAPPC5psi-mi:“MI:0915”(physical association)0.780
TRAPPC5CCNDBP1psi-mi:“MI:0915”(physical association)0.780
TRAPPC3TRAPPC5psi-mi:“MI:0915”(physical association)0.740
TUBA1CTXNDC9psi-mi:“MI:0914”(association)0.730
RAB3IPTRAPPC3psi-mi:“MI:0914”(association)0.700
KANK4TRAPPC3psi-mi:“MI:0914”(association)0.640
PTGR3DBTpsi-mi:“MI:0914”(association)0.640
IL13RA2CHEK1psi-mi:“MI:0914”(association)0.640
TRAPPC5HMG20Apsi-mi:“MI:0915”(physical association)0.560
TRAPPC2TRAPPC5psi-mi:“MI:0915”(physical association)0.560
TRAPPC2LTRAPPC13psi-mi:“MI:0914”(association)0.560
IL13RA2METTL15psi-mi:“MI:0914”(association)0.530
NPY2RRTL8Cpsi-mi:“MI:0914”(association)0.530
BTBD1TRAPPC10psi-mi:“MI:0914”(association)0.530
TRAPPC1TRAPPC13psi-mi:“MI:0914”(association)0.530
TPCN2AP3B1psi-mi:“MI:0914”(association)0.530
BCL2L14CHEK1psi-mi:“MI:0914”(association)0.530
CABS1TRAPPC10psi-mi:“MI:0914”(association)0.530
PRAMEF17CUL2psi-mi:“MI:0914”(association)0.530
LPAR1TMEM223psi-mi:“MI:0914”(association)0.530

BioGRID (189): TRAPPC5 (Two-hybrid), TRAPPC5 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC3 (Co-fractionation), TRAPPC5 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC1 (Affinity Capture-MS)

ESM2 similar proteins: A7RWP6, B4GW22, B4NC41, F1QMV3, F4JWP9, O43617, O55013, P34605, P36149, P45437, Q02880, Q08DS5, Q29G21, Q29G82, Q2NL13, Q32L78, Q4KL14, Q5BLF0, Q5F359, Q5R7L4, Q5RC82, Q5T215, Q5U1Z2, Q5ZI57, Q61IU9, Q62991, Q6GNS3, Q6P2Z0, Q6P2Z6, Q803N9, Q86K94, Q86SZ2, Q8AVM7, Q8BRF7, Q8IUR0, Q8K224, Q8WVM8, Q96D46, Q98SP7, Q99MH9

Diamond homologs: P15847, Q03337, Q2NL13, Q54YG5, Q5F359, Q7KQM2, Q8IUR0, Q9CQA1, Q9P7N9, Q8SU25

SIGNOR signaling

2 interactions.

AEffectBMechanism
TRAPPC5“form complex”“TRAPP III complex, TRAPPC2 variant”binding
TRAPPC5“form complex”“TRAPP III complex, TRAPPC2B variant”binding

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 108 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
RAB GEFs exchange GTP for GDP on RABs814.2×3e-05

GO biological processes:

GO termPartnersFoldFDR
obsolete vesicle tethering778.0×1e-09
COPII vesicle coat assembly539.5×2e-05
endoplasmic reticulum to Golgi vesicle-mediated transport913.7×4e-06

Disease & clinical

Clinical variants and AI predictions

ClinVar

23 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance21
Likely benign0
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

464 predictions. Top by Δscore:

VariantEffectΔscore
19:7682236:CCGCA:Cacceptor_loss1.0000
19:7682237:CGCAG:Cacceptor_loss1.0000
19:7682238:GCA:Gacceptor_loss1.0000
19:7682238:GCAGG:Gacceptor_loss1.0000
19:7682239:CA:Cacceptor_loss1.0000
19:7682240:A:ACacceptor_loss1.0000
19:7682240:A:AGacceptor_gain1.0000
19:7682240:AG:Aacceptor_gain1.0000
19:7682240:AGGGT:Aacceptor_gain1.0000
19:7682241:G:GGacceptor_gain1.0000
19:7682241:GG:Gacceptor_gain1.0000
19:7682241:GGGT:Gacceptor_gain1.0000
19:7682241:GGGTG:Gacceptor_gain1.0000
19:7682838:GA:Gdonor_gain1.0000
19:7682237:C:CAacceptor_gain0.9900
19:7682240:AGG:Aacceptor_gain0.9900
19:7682241:G:GTacceptor_gain0.9900
19:7682241:GGG:Gacceptor_gain0.9900
19:7682832:A:Gdonor_gain0.9900
19:7680878:GGTGA:Gdonor_loss0.9800
19:7680879:G:GAdonor_loss0.9800
19:7680880:T:Adonor_loss0.9800
19:7682779:G:GTdonor_gain0.9800
19:7682782:G:GTdonor_gain0.9800
19:7682899:A:AGdonor_gain0.9800
19:7682900:G:GGdonor_gain0.9800
19:7680881:G:GTdonor_loss0.9700
19:7680879:G:GGdonor_gain0.9600
19:7681012:G:GTdonor_gain0.9600
19:7682829:GAGA:Gdonor_gain0.9600

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000083785 (19:7680485 C>T), RS1000136938 (19:7681974 G>A,C,T), RS1000190338 (19:7687348 G>A), RS1000464639 (19:7682298 C>T), RS1001069294 (19:7683587 G>C,T), RS1001094088 (19:7679301 CGTGT>C,CGT), RS1001289345 (19:7684049 G>A), RS1001541746 (19:7683313 G>A,T), RS1001734944 (19:7681232 G>A), RS1001967496 (19:7679156 T>C), RS1002110087 (19:7684568 C>T), RS1002482388 (19:7684859 T>G), RS1002579530 (19:7678903 C>A,G,T), RS1002969179 (19:7680321 C>T), RS1003001701 (19:7680079 G>A,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL4295892 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

16 total (human), top 16 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, increases expression3
Cadmium Chlorideincreases abundance, increases expression2
aristolochic acid Iincreases expression1
triphenyl phosphateaffects expression1
decabromobiphenyl etheraffects expression1
tris(2-butoxyethyl) phosphateaffects expression1
arseniteaffects binding, increases reaction1
diallyl trisulfideincreases expression1
ICG 001decreases expression1
(+)-JQ1 compounddecreases expression1
Benzo(a)pyreneincreases methylation1
Cadmiumincreases abundance, increases expression1
Carcinogensdecreases expression1
Mutagensdecreases expression1
Smokedecreases expression1
Lactic Aciddecreases expression1

ChEMBL screening assays

1 unique, capped per target: 1 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL4118950BindingBinding affinity to TRAPPC5 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assayStudies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors. — Bioorg Med Chem

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.